Atlas Trials

Clinical Study of Hospital-manufactured CD19 CAR-T in Children and Adolescents With Acute Lymphoblastic Leukemia

Clinical trial NCT05210907 · RECRUITING

Trial details

NCT number
NCT05210907
Sponsor
Seoul National University Hospital
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
B-cell Acute Lymphoblastic Leukemia
Start date
2022-02-15
Primary completion
2025-09-30
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.